RT Journal Article
SR Electronic
T1 Genetically determined serum testosterone level and Covid-19 illness level: A mendelian randomization study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.10.21264779
DO 10.1101/2021.10.10.21264779
A1 Xiong, Juan
A1 Kong, Xuejun
A1 Ma, Ziyong
A1 Qu, Yifei
A1 Yang, Xu
A1 Miao, Ruicheng
A1 Huang, Jie
YR 2021
UL http://medrxiv.org/content/early/2021/10/13/2021.10.10.21264779.abstract
AB Background It is hypothesized that different levels of hormones especially serum testosterone level could explain the sex differences between men and women on the susceptibility and case fatality rate of COVID-19. However, traditional observational studies that support this hypothesis could not effectively establish the causal effects.Objective Utilizing recently published genome-wide associations studies (GWAS) on serum Testosterone level and on COVID-19 related phenotypes, we sought to assess the causality through Mendelian Randomization (MR) analyses. We further applied a suite of statistical genomics methods to further explore the biological mechanisms.Results We found that testosterone level is significantly associated with Covid-19 critical illness. All six MR methods yielded significant associations. There is no significant association between Testosterone and COVID-19 respiratory failure or COVID-19 susceptibility.Conclusion Based on the GWAS currently available, we provide support for a causal role of Testosterone on COVID-19 critical illness.Nevertheless, we recognize that the COVID-19 susceptibility GWAS effort is still ongoing and there is no such strong locus as CCR5 for HIV discovered for COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJuan Xiong was supported by The National Natural Science Foundation of China 81903412. Jie Huang was supported by Grant 2020YFC2002900 from the National Key Research and Development Program of China.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The GWAS summmary statistics can be obtained from GWAS Catalog https://www.ebi.ac.uk/gwas/. No individual level data was used.This analysis of publicly available data does not require ethical approval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors